4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000121
Chief Executive Officer sold 75,000 shares at $25.46 ($1,909,665)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Congleton Jon Chief Executive Officer | 2026-09-30 | Sale 10b5-1 | −75,000 | $25.46 | $1,909,665 | 528,621 | D |
| Open-market sales · 75,000 sh · avg $25.46 · $1,909,665 | |||||||
Loading xslF345X06/wk-form4_1790978009.xml…